Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Moderna Inc.

Start price
Target price
Perf. (%)
€162.42
21.03.22
€180.00
21.03.23
-2.20%
04.04.22

Revenue growth >5% per year expected
Differentiated customer and product portfolio
Future proof or reliable business model
Higher risks for its business
buy
Moderna Inc.

Start price
Target price
Perf. (%)
€160.00
18.03.22
€200.00
18.03.23
-12.75%
19.03.23

Could be worthwhile Investment >10% per year
Mullen Automotive Inc.

Start price
Target price
Perf. (%)
€2.62
18.03.22
-
18.03.23
0.02%
02.04.22

Risky Investment
buy
Roku

Start price
Target price
Perf. (%)
€110.50
18.03.22
€130.00
18.03.23
-20.36%
26.04.22

buy
Novocure Ltd

Start price
Target price
Perf. (%)
€64.20
16.03.22
€68.00
16.03.23
-6.99%
17.03.23

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
buy
Zoom Video Communications Inc

Start price
Target price
Perf. (%)
€95.29
16.03.22
€118.00
16.03.23
8.26%
09.08.22

Top 10 in its market
Future proof or reliable business model
negative Cash Flow expected
Significant cyclical dependencies
buy
Roku

Start price
Target price
Perf. (%)
€101.44
16.03.22
€88.00
16.03.23
-23.21%
11.06.22

Known brand
Normal challenges to pay loans and raise capital
Capable Management
Significant cyclical dependencies
buy
Royal Gold Inc.

Start price
Target price
Perf. (%)
€118.00
15.03.22
-
15.03.23
-4.79%
16.03.23

buy
Zynga Inc.

Start price
Target price
Perf. (%)
€8.02
14.03.22
€8.00
14.03.23
-3.14%
15.03.23

Capable Management
Very low/no dividend yield expected
Risky balance sheet
Few uniques
Roku

Start price
Target price
Perf. (%)
€92.32
14.03.22
€80.00
14.03.23
9.88%
16.03.22

Known brand
Normal challenges to pay loans and raise capital
Capable Management
Significant cyclical dependencies
Zoom Video Communications Inc

Start price
Target price
Perf. (%)
€88.75
14.03.22
€72.00
14.03.23
7.37%
16.03.22

Top 10 in its market
Future proof or reliable business model
negative Cash Flow expected
Significant cyclical dependencies
buy
Mullen Automotive Inc.

Start price
Target price
Perf. (%)
€1.47
13.03.22
-
13.03.23
-73.87%
21.10.22

Could be worthwhile Investment >10% per year
buy
Zoom Video Communications Inc

Start price
Target price
Perf. (%)
€91.24
12.03.22
-
12.03.23
-30.38%
13.03.23

buy
DocuSign Inc.

Start price
Target price
Perf. (%)
€69.51
11.03.22
€80.00
11.03.23
-33.82%
08.12.22

Could be worthwhile Investment >10% per year
buy
Mullen Automotive Inc.

Start price
Target price
Perf. (%)
€0.77
23.02.22
-
23.02.23
242.75%
18.03.22

Could be worthwhile Investment >10% per year
Moderna Inc.

Start price
Target price
Perf. (%)
€126.14
21.02.22
-
21.02.23
19.31%
22.02.23

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Rising EBIT margin expected
buy
Agios Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€25.74
20.02.22
€30.00
20.03.22
2.76%
21.03.22

Could be worthwhile Investment >10% per year
buy
Columbia Sportsware

Start price
Target price
Perf. (%)
€87.50
08.02.22
€90.00
08.02.23
-2.86%
09.02.23

Known brand
Probably not worthwhile Investment
overvalued
Low dividend yield expected
buy
Bluebird Bio Inc.

Start price
Target price
Perf. (%)
€6.22
06.02.22
-
06.02.23
-15.28%
20.02.22

Risky Investment
buy
Sealed Air Corp.

Start price
Target price
Perf. (%)
€57.50
05.02.22
-
05.02.23
4.35%
13.03.22

buy
Zoom Video Communications Inc

Start price
Target price
Perf. (%)
€128.96
30.01.22
€132.00
30.01.23
-31.18%
14.03.22

Top 10 in its market
Future proof or reliable business model
negative Cash Flow expected
Significant cyclical dependencies
buy
Signature Bank

Start price
Target price
Perf. (%)
€274.00
27.01.22
-
27.01.23
-57.77%
28.01.23

Zoom Video Communications Inc

Start price
Target price
Perf. (%)
€124.20
24.01.22
€112.00
24.01.23
3.83%
30.01.22

Top 10 in its market
Future proof or reliable business model
negative Cash Flow expected
Significant cyclical dependencies
buy
Moderna Inc.

Start price
Target price
Perf. (%)
€137.00
23.01.22
-
23.01.23
4.37%
06.02.22

Could be very worthwhile Investment >20% year
buy
Moderna Inc.

Start price
Target price
Perf. (%)
€137.00
22.01.22
€165.00
22.01.23
4.37%
06.02.22

Revenue growth >5% per year expected
Differentiated customer and product portfolio
Future proof or reliable business model
Higher risks for its business